Intrapatient dose escalation to 800 mg/m(2) pemetrexed is safe and feasible in patients with advanced non-small cell lung cancer (NSCLC) who have had prior chemotherapy.

Lee J., Hsia T., Yang C., Heo D., Chang G., Park K., ...More

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 13 - 17 May 2005, vol.23 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 23
  • City: Florida
  • Country: United States Of America
  • Eskisehir Osmangazi University Affiliated: Yes